e-learning
resources
Glasgow 2004
Monday 06.09.2004
Cardiovascular and metabolic consequences of OSA
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome
T. Akahoshi, T. Akashiba, N. Nomura, S. Kawahara, K. Katsura, T. Horie (Tokyo, Japan)
Source:
Annual Congress 2004 - Cardiovascular and metabolic consequences of OSA
Session:
Cardiovascular and metabolic consequences of OSA
Session type:
Thematic Poster Session
Number:
2093
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Akahoshi, T. Akashiba, N. Nomura, S. Kawahara, K. Katsura, T. Horie (Tokyo, Japan). Effect of continuous positive airway pressure treatment on elevated levels of C-reactive protein in patients with obstructive sleep apnea syndrome. Eur Respir J 2004; 24: Suppl. 48, 2093
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Evaluation of long-term effect of continuous positive airway pressure (CPAP) therapy on reduction of high sensitivity C-reactive protein (HSCRP) for patients with obstructive sleep apnea syndrome (OSAS)
Source: Eur Respir J 2005; 26: Suppl. 49, 357s
Year: 2005
Serum vitamin D levels in patients with obstructive sleep apnea syndrome and concentration changes after continuous positive airway pressure treatment
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Nasal continuous positive airway pressure treatment improves elevated soluble CD40 ligand in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 331s
Year: 2004
C-reactive protein levels in obstructive sleep apnea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 356s
Year: 2005
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007
Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP
Source: Eur Respir J 2007; 30: 496-500
Year: 2007
Endothelial and systemic inflammation in obstructive sleep apnea syndrome: Impact of CPAP therapy on CRP plasma levels
Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Year: 2010
Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 332s
Year: 2004
Effect and significance of continuous positive airway pressure treatment on vascular endothelial function in patients with obstructive sleep apnoea syndrome
Source: Annual Congress 2003 - Systematic inflammation and metabolic disorders in sleep related breathing disorders
Year: 2003
The influence of 3-weeks‘ therapy of continous positive airway pressure (CPAP) on serum leptin and homocysteine concentration in patients with obstructive sleep apnea (OSA)
Source: Annual Congress 2005 - Metabolic control in OSA
Year: 2005
Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013
Effect of continuous positive airway pressure treatment (CPAP) in angiogenic growth factors‘ expression in patients with COPD and obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
C-reactive protein (CRP) levels in obstructive sleep apnea (OSA) patients and relation to severity of OSA
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2003; 22: Suppl. 45, 566s
Year: 2003
Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea
Source: Eur Respir J 2008; 32: 1009-1015
Year: 2008
Dynamics of metabolic parameters after 3 days continuous positive airway pressure in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006
Continuous positive airway pressure treatment associates with decreasing glycosylated hemoglobin (HbA
1
c) even in euglycemic obstructive sleep apnoea patients within normal HbA
1
c range
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept